Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only)
Clinical trial NCT05399459 · COMPLETED
Trial details
- NCT number
- NCT05399459
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-09
- Primary completion
- 2024-01-19
- Enrollment
- 897
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.